Ambagon Therapeutics
Biotechnology company developing cancer molecule therapeutics.
Ambagon Therapeutics has raised €75M across 1 funding round from 8 investors, most recently a Series A round in Jan 2022. Based in Eindhoven, Netherlands; active in Healthtech. Data as of 28 Oct 2026.
Eindhoven, Netherlandswww.ambagontx.com ↗
Total raised
€75M
€75,234,555
Funding rounds
1
Investors
8
distinct backers
Active since
2022-01
latest 2022-01
Funding by year
EUR raised per yearAmbagon Therapeutics — funding by year — interactive chart.
Data table
| Ambagon Therapeutics — funding by year | |
|---|---|
| 2022 | €75M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-01-07 | Series A | €75M | AbbVie Ventures,Droia Ventures,INKEF Capital,Mission BioCapital,MRL Ventures Fund,Nextech Invest+2 more | View deal → |
Investors
8Related news
- Biotech startup Ambagon Therapeutics raises €75.1M from Amsterdam-based Inkef Capital, otherssiliconcanals.com · 2022-01
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData